 normal leukem hematopoiet cell differenti sensit inhibitori effect c-myb antisens oligodeoxynucleotid vitro studi relev marrow purg c-myb protooncogen hematopoiet cell encod protein myb hematopoiet cell prolifer rel myb depend normal leukem human hematopoiet progenitor cell normal bone marrow cell sever type leukem blast cell mixtur normal leukem cell presenc c-myb sens antisens oligodeoxynucleotid cell viabil effici c-myb sens oligom neglig effect normal leukem cell contrast c-myb antisens oligom abolish clonogen growth t-cell leukemia line primari acut myelogen leukemia case primari chronic myelogen leukemia cml case blast crisi latter patient polymeras chain reaction analysi mixtur c-myb antisense-tr normal cml cell complet absenc bcr-abl express cml clonogen unit cultur antisens dose leukem cell growth normal hematopoiet progenitor cell normal leukem hematopoiet cell differenti sensit toxic effect c-myb antisens dna perturb c-myb function antisens oligodeoxynucleotid basi molecular approach therapi ex bone marrow agent